

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.18054165 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.58217736 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 5.52604771 |
| 4 | vocalization behavior (GO:0071625) | 5.34764669 |
| 5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.30513442 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.29377943 |
| 7 | glutamate secretion (GO:0014047) | 5.28380279 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.24043376 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.08697448 |
| 10 | locomotory exploration behavior (GO:0035641) | 5.04271369 |
| 11 | protein localization to synapse (GO:0035418) | 4.97397810 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.96726875 |
| 13 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.95162562 |
| 14 | neuron cell-cell adhesion (GO:0007158) | 4.77682384 |
| 15 | behavioral response to nicotine (GO:0035095) | 4.75814131 |
| 16 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.57861736 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 4.56719945 |
| 18 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.54708793 |
| 19 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.44360715 |
| 20 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.34638828 |
| 21 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.30783895 |
| 22 | neurotransmitter secretion (GO:0007269) | 4.30603160 |
| 23 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.25345440 |
| 24 | exploration behavior (GO:0035640) | 4.23810660 |
| 25 | synaptic transmission, glutamatergic (GO:0035249) | 4.11045252 |
| 26 | neuronal action potential propagation (GO:0019227) | 4.05884323 |
| 27 | establishment of mitochondrion localization (GO:0051654) | 4.03976688 |
| 28 | regulation of synapse structural plasticity (GO:0051823) | 4.03693741 |
| 29 | nucleobase catabolic process (GO:0046113) | 3.99537331 |
| 30 | neuron-neuron synaptic transmission (GO:0007270) | 3.99419643 |
| 31 | glutamate receptor signaling pathway (GO:0007215) | 3.97639200 |
| 32 | proline transport (GO:0015824) | 3.84430078 |
| 33 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.81690225 |
| 34 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.79530642 |
| 35 | layer formation in cerebral cortex (GO:0021819) | 3.77342889 |
| 36 | positive regulation of membrane potential (GO:0045838) | 3.70975388 |
| 37 | neuron recognition (GO:0008038) | 3.65199824 |
| 38 | dendritic spine morphogenesis (GO:0060997) | 3.64743999 |
| 39 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.64184578 |
| 40 | postsynaptic membrane organization (GO:0001941) | 3.64099685 |
| 41 | regulation of postsynaptic membrane potential (GO:0060078) | 3.61472135 |
| 42 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.61321657 |
| 43 | mitochondrion transport along microtubule (GO:0047497) | 3.61321657 |
| 44 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.61148889 |
| 45 | positive regulation of synapse maturation (GO:0090129) | 3.60859404 |
| 46 | activation of protein kinase A activity (GO:0034199) | 3.59035409 |
| 47 | long-term memory (GO:0007616) | 3.56660453 |
| 48 | regulation of synaptic plasticity (GO:0048167) | 3.55626773 |
| 49 | regulation of glutamate secretion (GO:0014048) | 3.52400878 |
| 50 | long-term synaptic potentiation (GO:0060291) | 3.50483534 |
| 51 | presynaptic membrane assembly (GO:0097105) | 3.49517294 |
| 52 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.48232435 |
| 53 | neuromuscular synaptic transmission (GO:0007274) | 3.47894877 |
| 54 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.47589379 |
| 55 | neurotransmitter transport (GO:0006836) | 3.45550642 |
| 56 | regulation of neurotransmitter secretion (GO:0046928) | 3.43838557 |
| 57 | neuronal ion channel clustering (GO:0045161) | 3.43819475 |
| 58 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.43710101 |
| 59 | regulation of synapse maturation (GO:0090128) | 3.43417085 |
| 60 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.42499503 |
| 61 | cerebellar granule cell differentiation (GO:0021707) | 3.39818078 |
| 62 | phosphorelay signal transduction system (GO:0000160) | 3.39401552 |
| 63 | synaptic vesicle endocytosis (GO:0048488) | 3.38102486 |
| 64 | positive regulation of neurotransmitter transport (GO:0051590) | 3.37513623 |
| 65 | regulation of vesicle fusion (GO:0031338) | 3.35878068 |
| 66 | axonal fasciculation (GO:0007413) | 3.32164474 |
| 67 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.31806790 |
| 68 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.30760164 |
| 69 | positive regulation of dendritic spine development (GO:0060999) | 3.30615947 |
| 70 | behavioral defense response (GO:0002209) | 3.29986566 |
| 71 | behavioral fear response (GO:0001662) | 3.29986566 |
| 72 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.29315517 |
| 73 | cell differentiation in hindbrain (GO:0021533) | 3.26168651 |
| 74 | auditory behavior (GO:0031223) | 3.26089738 |
| 75 | response to histamine (GO:0034776) | 3.26055687 |
| 76 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.25371137 |
| 77 | central nervous system myelination (GO:0022010) | 3.24679792 |
| 78 | axon ensheathment in central nervous system (GO:0032291) | 3.24679792 |
| 79 | gamma-aminobutyric acid transport (GO:0015812) | 3.24578055 |
| 80 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.22758502 |
| 81 | cell migration in hindbrain (GO:0021535) | 3.21608251 |
| 82 | adult walking behavior (GO:0007628) | 3.21089305 |
| 83 | regulation of neurotransmitter levels (GO:0001505) | 3.20811063 |
| 84 | dopamine receptor signaling pathway (GO:0007212) | 3.19744084 |
| 85 | regulation of neurotransmitter transport (GO:0051588) | 3.19154931 |
| 86 | presynaptic membrane organization (GO:0097090) | 3.18974610 |
| 87 | transmission of nerve impulse (GO:0019226) | 3.18721492 |
| 88 | mechanosensory behavior (GO:0007638) | 3.17336835 |
| 89 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.16373146 |
| 90 | fear response (GO:0042596) | 3.15406400 |
| 91 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.15222290 |
| 92 | regulation of female receptivity (GO:0045924) | 3.13792825 |
| 93 | detection of calcium ion (GO:0005513) | 3.12904983 |
| 94 | membrane depolarization (GO:0051899) | 3.11562448 |
| 95 | serotonin metabolic process (GO:0042428) | 3.11529359 |
| 96 | neuronal action potential (GO:0019228) | 3.10689154 |
| 97 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.10477558 |
| 98 | positive regulation of synaptic transmission (GO:0050806) | 3.08700560 |
| 99 | negative regulation of dendrite development (GO:2000171) | 3.06388925 |
| 100 | membrane depolarization during action potential (GO:0086010) | 3.05946730 |
| 101 | response to auditory stimulus (GO:0010996) | 3.05944634 |
| 102 | neurofilament cytoskeleton organization (GO:0060052) | 3.04664956 |
| 103 | learning (GO:0007612) | 3.04590243 |
| 104 | prepulse inhibition (GO:0060134) | 3.04033223 |
| 105 | neuromuscular process controlling posture (GO:0050884) | 3.02946934 |
| 106 | negative regulation of amino acid transport (GO:0051956) | 3.02366681 |
| 107 | vesicle transport along microtubule (GO:0047496) | 3.02304802 |
| 108 | female mating behavior (GO:0060180) | 3.01922438 |
| 109 | regulation of synaptic transmission (GO:0050804) | 3.01455170 |
| 110 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.01209634 |
| 111 | neuromuscular process controlling balance (GO:0050885) | 3.00804799 |
| 112 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.00694328 |
| 113 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.00490008 |
| 114 | primary amino compound metabolic process (GO:1901160) | 2.99789347 |
| 115 | innervation (GO:0060384) | 2.99247974 |
| 116 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.99244346 |
| 117 | behavioral response to cocaine (GO:0048148) | 2.97771384 |
| 118 | * synaptic transmission (GO:0007268) | 2.97199352 |
| 119 | multicellular organismal signaling (GO:0035637) | 2.96913226 |
| 120 | regulation of microtubule-based movement (GO:0060632) | 2.96627872 |
| 121 | synapse assembly (GO:0007416) | 2.96615327 |
| 122 | regulation of synaptic transmission, GABAergic (GO:0032228) | 2.95894464 |
| 123 | cellular potassium ion homeostasis (GO:0030007) | 2.94731451 |
| 124 | membrane hyperpolarization (GO:0060081) | 2.94223352 |
| 125 | mating behavior (GO:0007617) | 2.93974800 |
| 126 | positive regulation of synapse assembly (GO:0051965) | 2.93204448 |
| 127 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.91485724 |
| 128 | intraspecies interaction between organisms (GO:0051703) | 2.89236462 |
| 129 | startle response (GO:0001964) | 2.88068347 |
| 130 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.85154318 |
| 131 | positive regulation of meiosis (GO:0045836) | 2.80570253 |
| 132 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.79417478 |
| 133 | regulation of dendritic spine development (GO:0060998) | 2.76193503 |
| 134 | synapse organization (GO:0050808) | 2.73681310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.36774755 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.72598174 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.21337393 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.02630216 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.99133135 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.93583176 |
| 7 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.75239892 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.66686059 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.65665463 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.61015409 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.61015409 |
| 12 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.57719348 |
| 13 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.57059360 |
| 14 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.53977774 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.53665923 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.48607629 |
| 17 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.46165910 |
| 18 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.45850165 |
| 19 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.39001218 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.27046294 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.25609975 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.24949825 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.24470747 |
| 24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.19860159 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.10298921 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.99811385 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.98633376 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.98121969 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.92472003 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.86132291 |
| 31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.78168256 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.67265120 |
| 33 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.62530182 |
| 34 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.61854696 |
| 35 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.58891575 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.56381869 |
| 37 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.51478422 |
| 38 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.51026459 |
| 39 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.49920796 |
| 40 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.48465240 |
| 41 | P300_19829295_ChIP-Seq_ESCs_Human | 1.45277023 |
| 42 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.44238343 |
| 43 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39412884 |
| 44 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.39224421 |
| 45 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.33977518 |
| 46 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.32694036 |
| 47 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.32494691 |
| 48 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32450087 |
| 49 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29257740 |
| 50 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28840180 |
| 51 | AR_25329375_ChIP-Seq_VCAP_Human | 1.28676225 |
| 52 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.28349171 |
| 53 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.28158382 |
| 54 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28039109 |
| 55 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.24532886 |
| 56 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.22422592 |
| 57 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22265510 |
| 58 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.18973013 |
| 59 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.18356741 |
| 60 | STAT3_23295773_ChIP-Seq_U87_Human | 1.18234837 |
| 61 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17668340 |
| 62 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.17214658 |
| 63 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16151012 |
| 64 | VDR_22108803_ChIP-Seq_LS180_Human | 1.15163712 |
| 65 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12038398 |
| 66 | AR_19668381_ChIP-Seq_PC3_Human | 1.11886764 |
| 67 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.11368749 |
| 68 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09329352 |
| 69 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.08414309 |
| 70 | TCF4_23295773_ChIP-Seq_U87_Human | 1.05885298 |
| 71 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 1.03627045 |
| 72 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03058548 |
| 73 | FUS_26573619_Chip-Seq_HEK293_Human | 1.02360655 |
| 74 | JUN_21703547_ChIP-Seq_K562_Human | 1.01572937 |
| 75 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01232154 |
| 76 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00954513 |
| 77 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00822653 |
| 78 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.00737766 |
| 79 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.00372704 |
| 80 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.00214491 |
| 81 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.99094763 |
| 82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.97264366 |
| 83 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97143395 |
| 84 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.96579479 |
| 85 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.96497854 |
| 86 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.96033135 |
| 87 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95277655 |
| 88 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95220287 |
| 89 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.94943504 |
| 90 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94913437 |
| 91 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94846823 |
| 92 | * ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.94630730 |
| 93 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.93487348 |
| 94 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.92860991 |
| 95 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92429243 |
| 96 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.91576718 |
| 97 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.91410088 |
| 98 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.90923763 |
| 99 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90564637 |
| 100 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.90524672 |
| 101 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.88926432 |
| 102 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.88926432 |
| 103 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88666707 |
| 104 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.88140511 |
| 105 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.87910049 |
| 106 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.87493556 |
| 107 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87341044 |
| 108 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.85123564 |
| 109 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.84885548 |
| 110 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84177800 |
| 111 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.84177800 |
| 112 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.83920711 |
| 113 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.83824964 |
| 114 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.83122070 |
| 115 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82376443 |
| 116 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.81353928 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.13185904 |
| 2 | MP0003880_abnormal_central_pattern | 4.75002565 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 4.02964530 |
| 4 | MP0004270_analgesia | 3.71634176 |
| 5 | MP0002822_catalepsy | 3.47216918 |
| 6 | MP0009745_abnormal_behavioral_response | 3.42983192 |
| 7 | MP0001968_abnormal_touch/_nociception | 3.38903322 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.36172955 |
| 9 | MP0002064_seizures | 3.04525346 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.88862257 |
| 11 | MP0002734_abnormal_mechanical_nocicepti | 2.72067837 |
| 12 | MP0002735_abnormal_chemical_nociception | 2.69082715 |
| 13 | MP0002736_abnormal_nociception_after | 2.68663498 |
| 14 | MP0009046_muscle_twitch | 2.68440416 |
| 15 | MP0005423_abnormal_somatic_nervous | 2.59013926 |
| 16 | MP0002272_abnormal_nervous_system | 2.51377460 |
| 17 | MP0002733_abnormal_thermal_nociception | 2.27817573 |
| 18 | MP0001486_abnormal_startle_reflex | 2.27788052 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.20514618 |
| 20 | MP0006276_abnormal_autonomic_nervous | 2.18168663 |
| 21 | MP0001970_abnormal_pain_threshold | 2.13577980 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.12032882 |
| 23 | MP0002909_abnormal_adrenal_gland | 1.99960640 |
| 24 | MP0009780_abnormal_chondrocyte_physiolo | 1.96033003 |
| 25 | MP0002067_abnormal_sensory_capabilities | 1.91664298 |
| 26 | MP0003122_maternal_imprinting | 1.90447913 |
| 27 | MP0001984_abnormal_olfaction | 1.89523282 |
| 28 | MP0005645_abnormal_hypothalamus_physiol | 1.87478461 |
| 29 | MP0002184_abnormal_innervation | 1.87408844 |
| 30 | MP0005646_abnormal_pituitary_gland | 1.85005988 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.83434034 |
| 32 | MP0001529_abnormal_vocalization | 1.79384862 |
| 33 | MP0004811_abnormal_neuron_physiology | 1.77146314 |
| 34 | MP0005386_behavior/neurological_phenoty | 1.76224574 |
| 35 | MP0004924_abnormal_behavior | 1.76224574 |
| 36 | MP0003787_abnormal_imprinting | 1.71775567 |
| 37 | MP0004858_abnormal_nervous_system | 1.70004451 |
| 38 | MP0000778_abnormal_nervous_system | 1.68291285 |
| 39 | MP0003329_amyloid_beta_deposits | 1.62577989 |
| 40 | MP0003879_abnormal_hair_cell | 1.61027950 |
| 41 | MP0001905_abnormal_dopamine_level | 1.57009604 |
| 42 | MP0008569_lethality_at_weaning | 1.53980771 |
| 43 | MP0000955_abnormal_spinal_cord | 1.48195874 |
| 44 | MP0002882_abnormal_neuron_morphology | 1.37507824 |
| 45 | MP0002066_abnormal_motor_capabilities/c | 1.35395218 |
| 46 | MP0001188_hyperpigmentation | 1.34398896 |
| 47 | MP0001502_abnormal_circadian_rhythm | 1.32645253 |
| 48 | MP0004133_heterotaxia | 1.25951023 |
| 49 | MP0010386_abnormal_urinary_bladder | 1.25895437 |
| 50 | MP0000013_abnormal_adipose_tissue | 1.25355208 |
| 51 | MP0003633_abnormal_nervous_system | 1.16281869 |
| 52 | MP0004885_abnormal_endolymph | 1.15352477 |
| 53 | MP0004142_abnormal_muscle_tone | 1.14864706 |
| 54 | MP0002837_dystrophic_cardiac_calcinosis | 1.11762145 |
| 55 | MP0006292_abnormal_olfactory_placode | 1.11582634 |
| 56 | MP0004147_increased_porphyrin_level | 1.03502956 |
| 57 | MP0002152_abnormal_brain_morphology | 1.03042921 |
| 58 | MP0002069_abnormal_eating/drinking_beha | 1.02786627 |
| 59 | MP0000751_myopathy | 1.02250089 |
| 60 | MP0002653_abnormal_ependyma_morphology | 0.97687763 |
| 61 | MP0003631_nervous_system_phenotype | 0.97313849 |
| 62 | MP0008872_abnormal_physiological_respon | 0.94775554 |
| 63 | MP0002876_abnormal_thyroid_physiology | 0.92607349 |
| 64 | MP0008961_abnormal_basal_metabolism | 0.89380225 |
| 65 | MP0004130_abnormal_muscle_cell | 0.88759232 |
| 66 | MP0000026_abnormal_inner_ear | 0.88316069 |
| 67 | MP0005535_abnormal_body_temperature | 0.88294339 |
| 68 | MP0002229_neurodegeneration | 0.88262658 |
| 69 | MP0000631_abnormal_neuroendocrine_gland | 0.88192853 |
| 70 | MP0004085_abnormal_heartbeat | 0.87480652 |
| 71 | MP0006072_abnormal_retinal_apoptosis | 0.85533418 |
| 72 | MP0008874_decreased_physiological_sensi | 0.84702243 |
| 73 | MP0003283_abnormal_digestive_organ | 0.83883306 |
| 74 | MP0005394_taste/olfaction_phenotype | 0.83502758 |
| 75 | MP0005499_abnormal_olfactory_system | 0.83502758 |
| 76 | MP0003890_abnormal_embryonic-extraembry | 0.80414232 |
| 77 | MP0001664_abnormal_digestion | 0.79994827 |
| 78 | MP0003183_abnormal_peptide_metabolism | 0.79225996 |
| 79 | MP0002638_abnormal_pupillary_reflex | 0.78624013 |
| 80 | MP0002160_abnormal_reproductive_system | 0.76966960 |
| 81 | MP0005253_abnormal_eye_physiology | 0.75513463 |
| 82 | MP0001963_abnormal_hearing_physiology | 0.74485183 |
| 83 | MP0003123_paternal_imprinting | 0.74330101 |
| 84 | MP0002102_abnormal_ear_morphology | 0.73501142 |
| 85 | MP0002752_abnormal_somatic_nervous | 0.72025861 |
| 86 | MP0004742_abnormal_vestibular_system | 0.71588916 |
| 87 | MP0003011_delayed_dark_adaptation | 0.71174827 |
| 88 | MP0003634_abnormal_glial_cell | 0.70433092 |
| 89 | MP0005551_abnormal_eye_electrophysiolog | 0.69203898 |
| 90 | MP0002163_abnormal_gland_morphology | 0.68660098 |
| 91 | MP0005195_abnormal_posterior_eye | 0.68166566 |
| 92 | MP0002751_abnormal_autonomic_nervous | 0.68063370 |
| 93 | MP0003195_calcinosis | 0.67118952 |
| 94 | MP0001177_atelectasis | 0.67111561 |
| 95 | MP0004145_abnormal_muscle_electrophysio | 0.66144117 |
| 96 | MP0003121_genomic_imprinting | 0.65466556 |
| 97 | MP0008877_abnormal_DNA_methylation | 0.64937524 |
| 98 | MP0008875_abnormal_xenobiotic_pharmacok | 0.64836034 |
| 99 | MP0000604_amyloidosis | 0.64349976 |
| 100 | MP0003075_altered_response_to | 0.64013731 |
| 101 | MP0001986_abnormal_taste_sensitivity | 0.63692595 |
| 102 | MP0004043_abnormal_pH_regulation | 0.61725618 |
| 103 | MP0000427_abnormal_hair_cycle | 0.59284188 |
| 104 | MP0000920_abnormal_myelination | 0.58972373 |
| 105 | MP0003632_abnormal_nervous_system | 0.58924835 |
| 106 | MP0005448_abnormal_energy_balance | 0.57356622 |
| 107 | MP0003938_abnormal_ear_development | 0.56348297 |
| 108 | MP0005389_reproductive_system_phenotype | 0.55327014 |
| 109 | MP0002928_abnormal_bile_duct | 0.54857810 |
| 110 | MP0000569_abnormal_digit_pigmentation | 0.54174574 |
| 111 | MP0001485_abnormal_pinna_reflex | 0.53317893 |
| 112 | MP0001943_abnormal_respiration | 0.51430508 |
| 113 | MP0003137_abnormal_impulse_conducting | 0.51401268 |
| 114 | MP0003956_abnormal_body_size | 0.50725457 |
| 115 | MP0003861_abnormal_nervous_system | 0.50145564 |
| 116 | MP0005379_endocrine/exocrine_gland_phen | 0.49452964 |
| 117 | MP0004215_abnormal_myocardial_fiber | 0.48966047 |
| 118 | MP0005187_abnormal_penis_morphology | 0.48678264 |
| 119 | MP0002082_postnatal_lethality | 0.47042504 |
| 120 | MP0010770_preweaning_lethality | 0.47042504 |
| 121 | MP0004484_altered_response_of | 0.47000871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.45673411 |
| 2 | Myokymia (HP:0002411) | 6.86798767 |
| 3 | Focal seizures (HP:0007359) | 5.58363510 |
| 4 | Visual hallucinations (HP:0002367) | 5.37429663 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.91307474 |
| 6 | Atonic seizures (HP:0010819) | 4.70863618 |
| 7 | Febrile seizures (HP:0002373) | 4.24920670 |
| 8 | Absence seizures (HP:0002121) | 4.22376456 |
| 9 | Dialeptic seizures (HP:0011146) | 3.89530115 |
| 10 | Generalized tonic-clonic seizures (HP:0002069) | 3.84547893 |
| 11 | Progressive cerebellar ataxia (HP:0002073) | 3.70642578 |
| 12 | Hyperventilation (HP:0002883) | 3.56435380 |
| 13 | Broad-based gait (HP:0002136) | 3.27719531 |
| 14 | Depression (HP:0000716) | 3.23996619 |
| 15 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.22716846 |
| 16 | Ankle clonus (HP:0011448) | 3.19979323 |
| 17 | Amblyopia (HP:0000646) | 3.18840926 |
| 18 | Supranuclear gaze palsy (HP:0000605) | 3.17330500 |
| 19 | Poor eye contact (HP:0000817) | 3.16198268 |
| 20 | Anxiety (HP:0000739) | 3.15023171 |
| 21 | Action tremor (HP:0002345) | 3.13023219 |
| 22 | Abnormal eating behavior (HP:0100738) | 3.12282379 |
| 23 | Type II lissencephaly (HP:0007260) | 3.00854240 |
| 24 | Limb dystonia (HP:0002451) | 3.00206909 |
| 25 | Molar tooth sign on MRI (HP:0002419) | 2.92932925 |
| 26 | Abnormality of midbrain morphology (HP:0002418) | 2.92932925 |
| 27 | Mutism (HP:0002300) | 2.83386147 |
| 28 | Gaze-evoked nystagmus (HP:0000640) | 2.79935053 |
| 29 | Polyphagia (HP:0002591) | 2.79330200 |
| 30 | Abnormal social behavior (HP:0012433) | 2.78831259 |
| 31 | Impaired social interactions (HP:0000735) | 2.78831259 |
| 32 | Epileptiform EEG discharges (HP:0011182) | 2.78564066 |
| 33 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.77231701 |
| 34 | Truncal ataxia (HP:0002078) | 2.75577185 |
| 35 | Torticollis (HP:0000473) | 2.73103989 |
| 36 | Pheochromocytoma (HP:0002666) | 2.71615821 |
| 37 | Pancreatic fibrosis (HP:0100732) | 2.71038908 |
| 38 | Dysdiadochokinesis (HP:0002075) | 2.67303886 |
| 39 | EEG with generalized epileptiform discharges (HP:0011198) | 2.63708148 |
| 40 | Drooling (HP:0002307) | 2.63565876 |
| 41 | Excessive salivation (HP:0003781) | 2.63565876 |
| 42 | Dysmetria (HP:0001310) | 2.63201273 |
| 43 | Papilledema (HP:0001085) | 2.62942190 |
| 44 | Postural instability (HP:0002172) | 2.61028697 |
| 45 | Pancreatic cysts (HP:0001737) | 2.58387422 |
| 46 | Failure to thrive in infancy (HP:0001531) | 2.58234282 |
| 47 | Focal dystonia (HP:0004373) | 2.57931477 |
| 48 | Agitation (HP:0000713) | 2.56156088 |
| 49 | Congenital stationary night blindness (HP:0007642) | 2.55026375 |
| 50 | True hermaphroditism (HP:0010459) | 2.52967480 |
| 51 | Hypsarrhythmia (HP:0002521) | 2.52743698 |
| 52 | Gait imbalance (HP:0002141) | 2.52029085 |
| 53 | Progressive inability to walk (HP:0002505) | 2.51963571 |
| 54 | Urinary urgency (HP:0000012) | 2.49033747 |
| 55 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.47780586 |
| 56 | Nephronophthisis (HP:0000090) | 2.46917847 |
| 57 | Bradykinesia (HP:0002067) | 2.44118319 |
| 58 | Abnormality of the lower motor neuron (HP:0002366) | 2.40615791 |
| 59 | Neuroendocrine neoplasm (HP:0100634) | 2.40281158 |
| 60 | Lissencephaly (HP:0001339) | 2.37636459 |
| 61 | Cerebral inclusion bodies (HP:0100314) | 2.36797441 |
| 62 | Craniofacial dystonia (HP:0012179) | 2.34088885 |
| 63 | Termporal pattern (HP:0011008) | 2.33528191 |
| 64 | Insidious onset (HP:0003587) | 2.33528191 |
| 65 | Chronic hepatic failure (HP:0100626) | 2.33178327 |
| 66 | Hypoventilation (HP:0002791) | 2.31501877 |
| 67 | Impaired smooth pursuit (HP:0007772) | 2.30977725 |
| 68 | Spastic gait (HP:0002064) | 2.30805672 |
| 69 | Retinal dysplasia (HP:0007973) | 2.29788590 |
| 70 | Spastic tetraplegia (HP:0002510) | 2.23300716 |
| 71 | Menstrual irregularities (HP:0000858) | 2.22355876 |
| 72 | Abnormality of the corticospinal tract (HP:0002492) | 2.21676270 |
| 73 | Delusions (HP:0000746) | 2.21317495 |
| 74 | Genetic anticipation (HP:0003743) | 2.20656030 |
| 75 | Abnormal hair whorl (HP:0010721) | 2.19258010 |
| 76 | Stereotypic behavior (HP:0000733) | 2.18613547 |
| 77 | Poor suck (HP:0002033) | 2.18055226 |
| 78 | Abnormality of the labia minora (HP:0012880) | 2.15894819 |
| 79 | Pachygyria (HP:0001302) | 2.14548822 |
| 80 | Vaginal atresia (HP:0000148) | 2.14459055 |
| 81 | Inability to walk (HP:0002540) | 2.14439899 |
| 82 | Hemiparesis (HP:0001269) | 2.14256336 |
| 83 | Fetal akinesia sequence (HP:0001989) | 2.14234455 |
| 84 | Neurofibrillary tangles (HP:0002185) | 2.13928504 |
| 85 | Genital tract atresia (HP:0001827) | 2.13678185 |
| 86 | Diplopia (HP:0000651) | 2.11717289 |
| 87 | Abnormality of binocular vision (HP:0011514) | 2.11717289 |
| 88 | Resting tremor (HP:0002322) | 2.11449534 |
| 89 | Congenital primary aphakia (HP:0007707) | 2.08657438 |
| 90 | Abnormality of the renal medulla (HP:0100957) | 2.08594785 |
| 91 | Specific learning disability (HP:0001328) | 2.07892652 |
| 92 | Impaired vibratory sensation (HP:0002495) | 2.06551407 |
| 93 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.05649253 |
| 94 | Oligodactyly (hands) (HP:0001180) | 2.05008285 |
| 95 | Absent speech (HP:0001344) | 2.02922272 |
| 96 | Cerebellar dysplasia (HP:0007033) | 2.02841288 |
| 97 | Hyperthyroidism (HP:0000836) | 2.01327241 |
| 98 | Lower limb muscle weakness (HP:0007340) | 2.00811489 |
| 99 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.00285712 |
| 100 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.00285712 |
| 101 | Sleep apnea (HP:0010535) | 2.00266295 |
| 102 | Cerebral hypomyelination (HP:0006808) | 1.99043782 |
| 103 | Psychosis (HP:0000709) | 1.98807586 |
| 104 | Medial flaring of the eyebrow (HP:0010747) | 1.98485512 |
| 105 | Decreased central vision (HP:0007663) | 1.95519261 |
| 106 | Prolonged QT interval (HP:0001657) | 1.95270683 |
| 107 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.94599157 |
| 108 | Scanning speech (HP:0002168) | 1.94556694 |
| 109 | Blue irides (HP:0000635) | 1.93392838 |
| 110 | Generalized myoclonic seizures (HP:0002123) | 1.93372439 |
| 111 | Nephrogenic diabetes insipidus (HP:0009806) | 1.92131104 |
| 112 | Abnormality of pain sensation (HP:0010832) | 1.91813303 |
| 113 | Impaired pain sensation (HP:0007328) | 1.91813303 |
| 114 | Oligomenorrhea (HP:0000876) | 1.90138022 |
| 115 | Ventricular fibrillation (HP:0001663) | 1.88595924 |
| 116 | Cystic liver disease (HP:0006706) | 1.87320966 |
| 117 | Gait ataxia (HP:0002066) | 1.87288667 |
| 118 | Amyotrophic lateral sclerosis (HP:0007354) | 1.86951291 |
| 119 | Incomplete penetrance (HP:0003829) | 1.86905863 |
| 120 | Protruding tongue (HP:0010808) | 1.86667791 |
| 121 | Status epilepticus (HP:0002133) | 1.83892614 |
| 122 | Hemiplegia (HP:0002301) | 1.83891638 |
| 123 | Pendular nystagmus (HP:0012043) | 1.83825930 |
| 124 | Dysmetric saccades (HP:0000641) | 1.83179023 |
| 125 | Akinesia (HP:0002304) | 1.82868318 |
| 126 | Annular pancreas (HP:0001734) | 1.82690433 |
| 127 | Hypoplasia of the brainstem (HP:0002365) | 1.82359456 |
| 128 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.82359456 |
| 129 | Optic nerve hypoplasia (HP:0000609) | 1.81303740 |
| 130 | Abnormal EKG (HP:0003115) | 1.79233241 |
| 131 | Hypercortisolism (HP:0001578) | 1.78517067 |
| 132 | Intellectual disability, severe (HP:0010864) | 1.71589255 |
| 133 | Acute necrotizing encephalopathy (HP:0006965) | 1.71307641 |
| 134 | Polydipsia (HP:0001959) | 1.68598364 |
| 135 | Abnormal drinking behavior (HP:0030082) | 1.68598364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.49292199 |
| 2 | EPHA4 | 4.38308426 |
| 3 | MAP3K9 | 3.85408976 |
| 4 | MARK1 | 3.09543416 |
| 5 | CASK | 2.94891130 |
| 6 | MAP3K4 | 2.81549855 |
| 7 | DAPK2 | 2.70930808 |
| 8 | MAP3K12 | 2.63469664 |
| 9 | MINK1 | 2.61177041 |
| 10 | FRK | 2.59274026 |
| 11 | MAP2K7 | 2.58536600 |
| 12 | KSR2 | 2.24725771 |
| 13 | ARAF | 2.11389711 |
| 14 | NTRK2 | 1.96373071 |
| 15 | PAK6 | 1.89467069 |
| 16 | DAPK1 | 1.87975250 |
| 17 | KSR1 | 1.87480511 |
| 18 | PRKD3 | 1.80890516 |
| 19 | PLK2 | 1.80592940 |
| 20 | MAP2K4 | 1.77465411 |
| 21 | DYRK2 | 1.71933663 |
| 22 | GRK5 | 1.68574642 |
| 23 | RIPK4 | 1.62618978 |
| 24 | NTRK1 | 1.61544170 |
| 25 | PRPF4B | 1.56470946 |
| 26 | CDK5 | 1.51000959 |
| 27 | CDK19 | 1.49541197 |
| 28 | MAPK13 | 1.47251312 |
| 29 | CAMKK1 | 1.43296175 |
| 30 | SIK3 | 1.35450586 |
| 31 | WNK4 | 1.33709906 |
| 32 | MAP3K2 | 1.33490049 |
| 33 | TNIK | 1.32088703 |
| 34 | UHMK1 | 1.27650540 |
| 35 | PRKCG | 1.24254026 |
| 36 | MAP4K2 | 1.15884039 |
| 37 | SIK2 | 1.12330883 |
| 38 | PNCK | 1.12264384 |
| 39 | MAP3K13 | 1.10900104 |
| 40 | CAMKK2 | 1.07371231 |
| 41 | CAMK2A | 1.03392713 |
| 42 | INSRR | 1.02934265 |
| 43 | TLK1 | 0.99253814 |
| 44 | GRK1 | 0.99192454 |
| 45 | CDK18 | 0.96768723 |
| 46 | FES | 0.95187808 |
| 47 | CDK14 | 0.93067065 |
| 48 | SGK223 | 0.92308018 |
| 49 | SGK494 | 0.92308018 |
| 50 | PKN1 | 0.89195049 |
| 51 | BMPR1B | 0.89066507 |
| 52 | CDK15 | 0.89058268 |
| 53 | RAF1 | 0.87564223 |
| 54 | CAMK2B | 0.85321221 |
| 55 | PHKG1 | 0.84340928 |
| 56 | PHKG2 | 0.84340928 |
| 57 | BRAF | 0.83737898 |
| 58 | PTK2B | 0.83202314 |
| 59 | TAOK1 | 0.82768196 |
| 60 | PAK3 | 0.78268849 |
| 61 | STK38 | 0.78224221 |
| 62 | BMPR2 | 0.77485301 |
| 63 | SGK2 | 0.77153438 |
| 64 | CCNB1 | 0.76959642 |
| 65 | AKT3 | 0.76893951 |
| 66 | CDK11A | 0.76835125 |
| 67 | PRKCH | 0.75525439 |
| 68 | MAP2K6 | 0.75252013 |
| 69 | CAMK1 | 0.74544426 |
| 70 | MAP3K1 | 0.74098796 |
| 71 | BCR | 0.73641725 |
| 72 | TYRO3 | 0.72736080 |
| 73 | OXSR1 | 0.72357423 |
| 74 | LIMK1 | 0.72133261 |
| 75 | CSNK1G2 | 0.71432868 |
| 76 | LATS2 | 0.69046842 |
| 77 | RET | 0.68814121 |
| 78 | TAOK3 | 0.68706501 |
| 79 | NEK2 | 0.65776401 |
| 80 | DYRK1A | 0.64132050 |
| 81 | STK11 | 0.63564440 |
| 82 | WNK3 | 0.62436436 |
| 83 | SGK1 | 0.61981045 |
| 84 | PRKCE | 0.61528187 |
| 85 | MARK2 | 0.60552311 |
| 86 | NME1 | 0.59709159 |
| 87 | CAMK1G | 0.59451409 |
| 88 | MAP2K1 | 0.57817996 |
| 89 | FER | 0.55212302 |
| 90 | MAPK12 | 0.55065917 |
| 91 | MAP3K11 | 0.54747164 |
| 92 | PINK1 | 0.52575773 |
| 93 | RPS6KA2 | 0.51133506 |
| 94 | SGK3 | 0.50768667 |
| 95 | MAPK15 | 0.49925736 |
| 96 | DAPK3 | 0.49430153 |
| 97 | CSNK1G3 | 0.48892213 |
| 98 | ALK | 0.47758041 |
| 99 | CAMK2G | 0.47358066 |
| 100 | PRKCZ | 0.47202737 |
| 101 | PDK1 | 0.46600146 |
| 102 | PDPK1 | 0.46337895 |
| 103 | CAMK2D | 0.45700365 |
| 104 | ADRBK2 | 0.45342422 |
| 105 | CSNK1A1 | 0.44661690 |
| 106 | GRK7 | 0.41964991 |
| 107 | ADRBK1 | 0.41940943 |
| 108 | LMTK2 | 0.41051698 |
| 109 | RPS6KA3 | 0.40502668 |
| 110 | CSNK1D | 0.39775622 |
| 111 | ERBB2 | 0.39265151 |
| 112 | ERBB3 | 0.38463413 |
| 113 | CSNK1A1L | 0.37124781 |
| 114 | CAMK1D | 0.37033934 |
| 115 | PRKG1 | 0.36745532 |
| 116 | TNK2 | 0.36230653 |
| 117 | NUAK1 | 0.33606033 |
| 118 | STK39 | 0.33381727 |
| 119 | PRKCI | 0.33235330 |
| 120 | FGR | 0.32937790 |
| 121 | CSNK1G1 | 0.32830376 |
| 122 | CSNK1E | 0.32395233 |
| 123 | FYN | 0.32346127 |
| 124 | MAPK10 | 0.30973411 |
| 125 | CAMK4 | 0.30700701 |
| 126 | ZAK | 0.30159059 |
| 127 | PRKCB | 0.30062475 |
| 128 | CDC42BPA | 0.28892529 |
| 129 | TIE1 | 0.27928940 |
| 130 | PRKCA | 0.27643507 |
| 131 | PRKAA1 | 0.27361509 |
| 132 | PRKACA | 0.27287625 |
| 133 | PRKCQ | 0.26225480 |
| 134 | MAPK8 | 0.25156452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.76057816 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.64749500 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 3.04981958 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.72945609 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.70339901 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.66603257 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.64745987 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.63664386 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.58107103 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.46906186 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.35096472 |
| 12 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.28300248 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.22925154 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.22714960 |
| 15 | Salivary secretion_Homo sapiens_hsa04970 | 1.99354510 |
| 16 | Cocaine addiction_Homo sapiens_hsa05030 | 1.97068013 |
| 17 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.92531263 |
| 18 | Taste transduction_Homo sapiens_hsa04742 | 1.89705813 |
| 19 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.80781900 |
| 20 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.75274144 |
| 21 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.75143892 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.74234316 |
| 23 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.68300337 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.68227664 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.65208785 |
| 26 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.54968825 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.53649558 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.52933320 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.39306519 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.38728878 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.32353530 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.31084320 |
| 33 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.27993595 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.21231851 |
| 35 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.19890038 |
| 36 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.18786075 |
| 37 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.17964644 |
| 38 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.11856129 |
| 39 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.11784633 |
| 40 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.11292058 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.10891145 |
| 42 | Axon guidance_Homo sapiens_hsa04360 | 1.04290758 |
| 43 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.03770151 |
| 44 | Melanogenesis_Homo sapiens_hsa04916 | 1.02260321 |
| 45 | Glioma_Homo sapiens_hsa05214 | 1.01259065 |
| 46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.00789003 |
| 47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.99968692 |
| 48 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93203891 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.91739897 |
| 50 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91390241 |
| 51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.89307405 |
| 52 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.89110262 |
| 53 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.88777322 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 0.88086716 |
| 55 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.85479838 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.76937499 |
| 57 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.76576616 |
| 58 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74742467 |
| 59 | Alzheimers disease_Homo sapiens_hsa05010 | 0.74553868 |
| 60 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.74479646 |
| 61 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74216894 |
| 62 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.72783294 |
| 63 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.71541280 |
| 64 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.71537306 |
| 65 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.69287059 |
| 66 | Alcoholism_Homo sapiens_hsa05034 | 0.68750856 |
| 67 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.67237170 |
| 68 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.65696634 |
| 69 | Parkinsons disease_Homo sapiens_hsa05012 | 0.65659053 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.65567783 |
| 71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65064369 |
| 72 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64118758 |
| 73 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.63356223 |
| 74 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.61667284 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.61208239 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60634859 |
| 77 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.57869279 |
| 78 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.57115938 |
| 79 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56078823 |
| 80 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.56059101 |
| 81 | Prion diseases_Homo sapiens_hsa05020 | 0.54678307 |
| 82 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53774722 |
| 83 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.52670262 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51988744 |
| 85 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.48534266 |
| 86 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.48108656 |
| 87 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48067097 |
| 88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.46498708 |
| 89 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45108091 |
| 90 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.44672320 |
| 91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.44547744 |
| 92 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.43778029 |
| 93 | ABC transporters_Homo sapiens_hsa02010 | 0.43472340 |
| 94 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.43160937 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.43152022 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42509937 |
| 97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42371610 |
| 98 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41932908 |
| 99 | Circadian rhythm_Homo sapiens_hsa04710 | 0.41069478 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.40888065 |
| 101 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.40649193 |
| 102 | Huntingtons disease_Homo sapiens_hsa05016 | 0.39141656 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38955471 |
| 104 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37881688 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.37601623 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37359528 |
| 107 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.36315569 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34428906 |
| 109 | Phagosome_Homo sapiens_hsa04145 | 0.33696703 |
| 110 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.33196864 |
| 111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.33081977 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.32624753 |
| 113 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.32615820 |
| 114 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32274476 |
| 115 | Bile secretion_Homo sapiens_hsa04976 | 0.30804188 |
| 116 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.30401569 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.28942791 |
| 118 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28587630 |
| 119 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.27268538 |
| 120 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.25599314 |
| 121 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.24991480 |
| 122 | Peroxisome_Homo sapiens_hsa04146 | 0.24653205 |
| 123 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.24405734 |
| 124 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.24208871 |
| 125 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.23166171 |
| 126 | Mineral absorption_Homo sapiens_hsa04978 | 0.23065483 |
| 127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22260262 |

